array(2) { ["lab"]=> string(4) "1291" ["publication"]=> string(5) "12803" } Reprogramming of bivalent chromatin states in NRAS mutant melanoma suggests PRC2 inhibition as a therapeutic strategy - Medical Bioinformatics (Zhao Lab) | LabXing

Reprogramming of bivalent chromatin states in NRAS mutant melanoma suggests PRC2 inhibition as a therapeutic strategy